21 – 30 of 49
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2006
-
Mark
Pharmacokinetics, biodistribution, and antitumor efficacy of a human glandular kallikrein 2 (hK2)-activated thapsigargin prodrug
(
- Contribution to journal › Article
-
Mark
Immunohistochemical detection of cysteine-rich secretory protein 3 in tissue and in serum from men with cancer or benign enlargement of the prostate gland.
(
- Contribution to journal › Article
-
Mark
Identification of ABR-215050 as lead second generation quinoline-3-carboxamide anti-angiogenic agent for the treatment of prostate cancer.
(
- Contribution to journal › Article
- 2005
-
Mark
Assessment of intra-individual variation in prostate-specific antigen levels in a biennial randomized prostate cancer screening program in Sweden.
(
- Contribution to journal › Article
-
Mark
Expression of tumor-associated trypsinogens (TAT-1 and TAT-2) in prostate cancer.
(
- Contribution to journal › Article
-
Mark
Association of free-prostate specific antigen subfractions and human glandular kallikrein 2 with volume of benign and malignant prostatic tissue
(
- Contribution to journal › Article
-
Mark
Blood levels of free-PSA but not complex-PSA significantly correlates to prostate release of PSA in semen in young men, while blood levels of complex-PSA, but not free-PSA increase with age.
(
- Contribution to journal › Article
-
Mark
Relative concentrations of hK2/PSA mRNA in benign and malignant prostatic tissue
(
- Contribution to journal › Article
- 2004
-
Mark
Androgen receptor CAG repeat length correlates with semen PSA levels in adolescence.
(
- Contribution to journal › Article
-
Mark
Expression of serotonin receptors and role of serotonin in human prostate cancer tissue and cell lines.
(
- Contribution to journal › Article